Connection

Richard Silver to Enzyme Activators

Back to Details
This is a "connection" page, showing publications Richard Silver has written about Enzyme Activators.
Richard Silver
Connection Strength
0.176
Enzyme Activators
  1. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. Ann Rheum Dis. 2020 05; 79(5):618-625.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.